Holomycota

Apr 30, 2019

Caspofungin Market to Touch US$ 496.20 Million by 2027, Says TMR

Mar 12, 2019

Wheat Lines From 2Blades, CSIRO, and UMN Exhibit Exceptional Stem Rust Resistance in the Field

Feb 11, 2019

FDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis

Jan 18, 2019

Optimum Imaging Diagnostics (OIDx) is Proud to Announce the Release of Their First Commercial Test, the Histoplasma Capsulatum Urinary Antigen EIA Test

Nov 13, 2018

SCYNEXIS Reports Third Quarter 2018 Financial Results and Provides Company Update

Nov 13, 2018

Amplyx Doses First Patient in Phase 2 Trial of APX001 in Patients with Candida Infection

Oct 23, 2018

BioGX Launches 5 new CE Mark IVD Tests, Expands Sexual Health Panels on the BD MAX(TM)

Oct 15, 2018

SCYNEXIS, Inc. Announces First Patient Dosed in Phase 3 Open-label Study Evaluating Oral Ibrexafungerp in Candida auris Infections (CARES)

Oct 11, 2018

Global Yeast & Yeast Extract Markets to 2023: Growth, Trends and Forecasts - ResearchAndMarkets.com

Oct 01, 2018

SCYNEXIS Supports AMR Challenge and Fungal Disease Awareness Week

Sep 18, 2018

Cipher Pharmaceuticals Acquires Exclusive Canadian Rights to MOB-015 from Moberg Pharma for the topical treatment of Onychomycosis

Aug 07, 2018

How Much Do You Know About Yeast Extract? Take the Quiz and See!